Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous IgG in Atopic Dermatitis
NCT02835170Phase 3Completed
- Sponsor
- Ajou University School of Medicine
- Start
- Apr 2015
- Primary completion
- Mar 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of autologous immunoglobulin in atopic dermatitis (AD), sponsored by Ajou University School of Medicine. Started Apr 2015; status: completed.
02
Drugs
autologous immunoglobulin
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02835170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02835170.